Back to results
CompletedPhase 2

Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease

NCT04693520

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

St. Anne's University Hospital

Brno, Czechia

+5 additional locations

View on ClinicalTrials.gov
Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease — TrialFind